STAT+: Illumina says it will divest Grail, starting a closing chapter for a disastrous deal

Illumina, the leading maker of DNA sequencing machines, said it would divest Grail, developer of the Galleri multi-cancer screening test.
Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks